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Abstract
Pancreatic serous cystadenomas are rare benign cystic neoplasms. Extended operations are
unnecessary for serous cystadenomas and minimally invasive surgery should be performed.
Laparoscopic pancreatic procedures are under evaluation. We present a case of a 79-year-old Greek
woman with symptomatic cholelithiasis and a serous pancreatic cystadenoma located at the neck of
the pancreas. In the occasion of a standard laparoscopic cholecystectomy the pancreatic mass was
resected with a novel minimally invasive laparoscopic method preserving the integrity of the main
pancreatic duct and the whole pancreas. Laparoscopic resection is a feasible, safe and effective
treatment of benign pancreatic tumors, in experienced hands under proper indications.
Introduction
In the recent years, the advances in abdominal imaging
techniques have resulted into an increasing frequency of
pancreaticcysticneoplasmsidentification,whichareconsi-
dered to be rare. Pancreatic serous cystadenomas belong to
pancreatic cystic neoplasms and are considered to have
benign biological and clinical features and course. Serous
cystadenomas account for about 25% of all cystic tumors
of the pancreas [1,2].
Only relatively recently, Compagno and Oertel, described
in 1978 the morphological and clinical features of
this new entity, but there are still debating issues
regarding the optimal management and treatment of
these tumors [3].
Because it is difficult to establish a correct diagnosis of
the benign nature of the lesion pre-operatively, some
experts recommend resection of all pancreatic cystic
neoplasms [4,5], whereas others propose a more selective
approach recommending observation of the asympto-
matic serous cystadenomas and resection of the large,
symptomatic or indistinguishable from mucinous
neoplams cases [6,7].
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cystadenomas are resected even when they were small and
asymptomatic. Extended operations are unnecessary for
serous cystadenomas, and minimally invasive surgery
should be performed, because they are benign neoplasms
with only a slight malignant potential [8].
Laparoscopic pancreatic procedures, including the role of
laparoscopic surgery in patients with cystic neoplasms of
the pancreas, are under evaluation. Laparoscopic spleen-
preserving distal pancreatectomy for benign cystic
neoplasms in the body or the tail of the pancreas is a
safe and feasible option, in centers having experience in
both pancreatic surgery and laparoscopic procedures [9].
Case presentation
A 79-year-old Greek woman was referred to our depart-
ment for the management of discomfort in the upper
abdomen over the last 2-3 weeks, aggravated after food
ingestion. The patient was not a smoker or an alcohol
consumer and appeared healthy and well nourished. The
physical examination and laboratory examinations includ-
ing tumor markers were unremarkable.
An abdominal ultrasound (US) showed multiple stones in
the gallbladder without features of cholecystitis and a
multilocular cystic mass in the neck of the pancreas,
with max diameter 4 cm. For further clarification of the
US findings, Computed tomography (CT) (Figure 1) and
Magnetic Resonance Imaging (MRI) (Figures 2a, 2b &
Figure 3) of the abdomen were also performed and
revealed a homogenously hyper-intense multi-locular
cystic lesion with max diameter 4 cm, located in the
neck of the pancreas. Since it was difficult to conclude
preoperatively whether the mass of interest corresponded
to either a serous cystadenoma or a mucinous neoplasm or
a cystadenocarcinoma we scheduled to perform a typical
laparoscopic cholecystectomy in combination with
laparoscopic evaluation of the mass in order to obtain
a diagnosis and treatment if possible.
Under general anesthesia with the patient in the supine
position, a pneumoperitoneum was created by carbon
dioxide insufflation and four trocars were placed in the
typical locations for cholecystectomy. After typical laparo-
scopic cholecystectomy, a fifth 12 mm trocar was placed at
the outer verge of rectus abdominis muscle, in order to ease
further surgical manipulations. The gastrocolic ligament
was divided by Ligasure™ vessel sealing system and a
tumor of exophytic nature protruding from the pancreatic
parenchyma was noticed at the upper pancreatic margin at
the pancreatic neck. Because the tumor was quite mobile
and lacked adhesions with the neighboring tissues, it was
considered it could be excised en bloc laparoscopically
without harming the main pancreatic duct. After dissec-
tion of the tumor, ENDO GIA™ was used for tumor
excision from the pancreatic parenchyma and ENDO
CATCH™ was used to collect and remove the mass from
the peritoneal cavity (Figures 4 & 5).
Since the rapid histologic evaluation was negative for
malignancy, a drain was placed in the excision area. The
postoperative course was uneventful with a minor pan-
creaticleakageforthefirsttwodays.Thedrainwasremoved
on the fourth day and feeding was started at the same day.
The patient was discharged from the hospital seven days
after surgery.
The standard histopathological study of the removed mass
showed a serous microcystadenoma of the pancreas with
no evidence of malignancy. There were not any late
postoperative complications, while the patient remained
asymptomatic and exhibited no sign of recurrence
6 months after the operation.
Discussion
The cystic neoplasms of the pancreas are rare and represent
a diverse spectrum of disorders, which have differences in
the cells of origin, their biologic aggressiveness regarding
the natural history and the malignant potential, and their
management. In general they include four categories:
(a). Serous cystadenomas, (b). Mucinous cystic neoplasms
(MCNs; cystadenomas and cystadenocarcinomas), (c).
Intraductal papillary mucinous tumor (IPMT, or muci-
nous ductal ectasia), and (d) Unusual cystic neoplasms,
including the extremely rare cystic islet cell tumors
Figure 1. Contrast enhanced axial CT shows a well defined,
lobulated cystic mass with internal septations at the neck of
pancreas. Concomitant findings are cholelithiasis and an
adenoma of the left adrenal.
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cinomas, cystic choriocarcinomas, cystic teratomas, and
cystic lymphangiomatous neoplasms [10].
Pancreatic serous cystadenomas are rare neoplasms,
predominately affecting women (65%) at the seventh
decade of life. Small neoplasms are usually asymptomatic,
and the symptoms, most of which are non-specific, are
caused primarily by a large space-occupying tumor mass.
Systemic symptoms such as weight loss, malaise, anorexia,
and fatigue are rare. The majority of the serous cystic
neoplasms are found incidentally during the evaluation
for unrelated intra-abdominal disorders or symptoms.
They can be located anywhere in the pancreas [10].
A recent single-center study presented their experience of a
large series of 106 patients with pancreatic serous
cystadenoma [6]. In this study, it was observed
a preponderance in female gender (75%) in the seventh
decade of life, while almost half of the tumors were found
incidentally. There was only a slight difference between
proximal or distal location of the tumors; 44% were found
in the head, neck or uncinate process of the pancreas
versus 56% found in the body or the tail of the pancreas.
Almost 50% of the patients were symptomatic presenting
mainly with abdominal pain or fullness. Symptoms
correlated with tumor size since tumors <4 cm were less
likely to be symptomatic, but not with tumor location [6].
Most serous cystadenomas are microcystic composed of
multiple small (<2 cm) cystic areas, forming a character-
istic honeycomb-like appearance, which is observed
grossly and on imaging, but also macrocystic variants
have been rarely reported. In general, the improvement in
abdominal imaging techniques (CT scanning, transcuta-
neous or endoscopic ultrasonography, and MR imaging)
has offered the ability of non-invasive diagnosis with high
accuracy in 90% of cases [6].
Since the majority of these tumors are benign, with only
a few case reports of serous cystadenocarcinomas, the
Figure 2. Coronal T2 weighted (a) and axial T2 weighted fat saturated (b) MRI reveal a multiloculated cystic mass at the
pancreatic neck. A simple cyst at the left lobe of the liver is also seen at the coronal plane (a).
Figure 3. Gadolinium enhanced, fat saturated, gradient echo
axial MRI disclose complete absence of enhancement of the
mass at the pancreatic neck consistent with its cystic nature.
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suggest that the surgical resection of these tumors is
recommended when they are large (more than 4 cm in
maximal diameter) and symptomatic, or when the
imaging techniques are unable to distinguish a serous
cystic neoplasm from a mucinous lesion, which has greater
malignant potential [6]. On the opposite, asymptomatic
tumors with maximal diameter less than 4 cm should be
clinically followed up together with serial imaging,
perhaps every 2 years, for growth rate estimation [6].
When the cystic tumors are located in the body or tail of
the pancreas a classical or laparoscopic distal pancreatect-
omy with or without splenic preservation can be
performed [11,12]. When the tumors are located at the
pancreatic head or neck traditionally pancreatico-
duodenenectomy with classical Whipple’s procedure is
required. However, limitedresections, such as enucleation,
duodenum-preserving pancreatic head resection, or med-
ian pancreatectomy, are possible when resecting small
pancreatic tumors, to preserve as many functional
parenchyma and structures as possible [12,13].
In our case, since pre-operative imaging studies including
percutaneous US, CT, MRI could not accurately define the
benignormalignantnatureofthemass(serousormucinus
neoplasmofthepancreas),wedecidedtoperformatypical
laparoscopiccholecystectomyforsymptomaticcholelithia-
siscombinedwithlaparoscopicexplorationandevaluation
of the pancreatic tumor nature. With the laparoscopic
procedure we had the opportunity to approach the mass,
confine its resectability, and resect the cystic lesion at the
same time.
There are some important issues regarding the optimal
management of the serous pancreatic cystadenomas and
our approach for the treatment of this neoplasm. Although
the advances in abdominal imaging techniques have
resulted into an increasing frequency of pancreatic cystic
neoplasms identification they can not always accurately
predict the benign or malignant nature of the cystic tumors
of the pancreas [6]. Moreover, even when the diagnosis
of serous cystadenoma is firm, there have been no data
to date that allow one to safely predict the course of
thistumorwhichmaysometimesgrowsufficientlytocause
symptoms or have a malignant transformation during the
lifespan of a given patient [14]. Consequently, despite the
fact that we knew that the asymptomatic tumor was not
very large (4 cm in diameter) we decided to resect the
tumor, contrary to most experts’ recommendations
and confirmed the benign nature of the mass (serous
cystadenoma) before the completion of the operation.
There are improvements in pancreatic surgery (open or
laparoscopic) with reduction of mortality rates, but the
morbidity remains high and the consequences of loss of
pancreatic tissue are serious [6]. In our case, the location
and the protruding nature of the tumor, gave us the
opportunity to resect the cystic mass from the pancreatic
neck performing a laparoscopic method with minimal
segmental resection of pancreatic parenchyma without
harming the splenic vessels and the main pancreatic
duct, while preserving the integrity of the whole
pancreas. Otherwise we should perform a major resec-
tion performing open distal pancreatectomy with or
without spleen-preserving or a more limited resection
Figure 4. Laparoscopic macroscopic view of the serous
cystadenoma at the pancreatic neck.
Figure 5. Laparoscopic view of the excision line at the
pancreas after the resection of the pancreatic serous
cystadenoma with ENDOGIA™.
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pancreatectomy [13,15].
With this minimally invasive procedure we treated
simultaneously the cholelithiasis and the cystic mass of
the pancreas, avoiding two separate operations and
perhaps a more invasive operation for this benign
pancreatic lesion. With this technique we preserved the
integrity of the whole pancreatic tissue since only
a peripheral slide of pancreatic parenchyma was excised
together with the mass, while maintaining the upper
digestive and biliary anatomy and preserving the spleen.
Furthermore there were no short- or long-term post-
operative complications.
Conclusion
Pancreatic serous cystadenoma is a benign tumor but
imaging modalities are often difficult to distinguish it
from malignant pancreatic cystic tumors. If the diagnosis
of a serous cystadenoma is certain, surgery is recom-
mended for large tumors and symptomatic patients, but if
the diagnosis is questionable, it is better to resect the
tumors under acceptable surgical risks, with the most
limited and minimal method. We presented a case of
pancreatic serous cystadenoma, which was treated with a
novel minimally invasive laparoscopic method combined
with standard laparoscopic cholecystectomy. In our
opinion the laparoscopic resection is a feasible, safe and
effective treatment of benign pancreatic tumors, in
experienced hands under proper indications and optimal
circumstances.
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